About Anavex (AVXL)
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to tr... Read more
- USD9.46
- USD9.65
- USD9.31
- USD14.44
- -1.50%
- --
- 8.00
- 1.07M
- 761M
- 3.41
- 177.90%
Stock News
yesterday
U.S. stock futures fall ahead of big week for tech earnings
MarketWatch
yesterday
This is the secret sauce to stock-picking — and what went wrong in my sale of Alphabet
CNBC
yesterday
2 Cash-Producing Stocks with Exciting Potential and 1 to Question
Yahoo
yesterday
Vale Q1: Still Undervalued? Let's Revisit The Thesis After A Challenging Quarter
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
